Orchestra BioMed (NASDAQ:OBIO) Research Coverage Started at BTIG Research
BTIG Research initiated coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $12.00 target price on the stock. Several other analysts have also recently commented on OBIO. Barclays began coverage on shares of Orchestra BioMed in […]
BTIG Research initiated coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $12.00 target price on the stock. Several other analysts have also recently commented on OBIO. Barclays began coverage on shares of Orchestra BioMed in […]
